RxDoctor Payments Data

John Evans

Adult Health · Dothan, ALNPI 1083033286

Payments from drug & device makers

$1,211in general payments, 2019–2025

Across 80 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$277
  • GSK$143
  • Novo Nordisk$135
  • AbbVie$98
  • AstraZeneca$97
  • Medtronic$65
  • plus $397 from 14 others

What the payments were for

  • Food & beverage$1,15996%
  • Other$524%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,211 in reported general payments places this provider in the 65th percentile of 308 adult health providers in Alabama.

See all adult health providers in Alabama

Medicare billing

Part B allowed, 2024
$1,118
Medicare patients
15
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$83,306
MounjaroTirzepatide53$58,145
JardianceEmpagliflozin52$54,125
EliquisApixaban35$35,334
XareltoRivaroxaban38$31,533
FarxigaDapagliflozin Propanediol22$25,512
Breo ElliptaFluticasone/Vilanterol46$18,163
MyrbetriqMirabegron23$17,171
JanuviaSitagliptin Phosphate12$15,426
TrulicityDulaglutide12$11,764
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,923
BelsomraSuvorexant18$7,851
BrilintaTicagrelor11$4,624
NexiumEsomeprazole Magnesium12$3,223
Levothyroxine Sodium156$2,297

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$135$83,30687 claims
Lilly USA, LLCMounjaro, Trulicity$61$69,91065 claims
PfizerEliquis, Paxlovid$55$36,76347 claims
AstraZenecaFarxiga, Brilinta, Nexium$97$33,35945 claims
GSKBreo Ellipta, Trelegy Ellipta$143$28,08660 claims
MerckJanuvia, Belsomra$12$23,27730 claims
Astellas Pharma US IncMyrbetriq$49$17,17123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 308 adult health providers in Alabama.

Other adult health in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →